Industry News

Industry News

Outcome in HPV-related oral cancers not necessarily predicted by number of cancer stem cells

Jan 24, 2014

New research from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that it may be the quality of cancer stem cells rather than their quantity that leads to better survival in certain patients with oral cancer. Read More

Folic acid linked to breast cancer growth in animal study

Jan 23, 2014

Folic acid is a well-known supplement to many women, particularly those who are or plan to be pregnant. But a new study suggests that taking large amounts of folate - a B vitamin - and its synthetic form, folic acid, might actually increase the risk of developing breast cancer. Read More

Inherited gene mutations found in 20% of women with ovarian cancer

Jan 23, 2014

Genetic studies of inherited predisposition to ovarian cancer have tended to focus on women with a known family history of the disease. Now, a new study of ovarian cancer patients with no known family history of the disease found one fifth of them had inherited alterations in genes known to be linked to ovarian and breast cancer. Read More

Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence

Jan 23, 2014

Girls treated for Hodgkin's disease during adolescence acquire a considerable risk of developing breast cancer, as shown by an observational study published in the current issue of Deutsches Ă„rzteblatt International. Read More

Inherited gene mutations found in 20% of women with ovarian cancer

Jan 23, 2014

Genetic studies of inherited predisposition to ovarian cancer have tended to focus on women with a known family history of the disease. Now, a new study of ovarian cancer patients with no known family history of the disease found one fifth of them had inherited alterations in genes known to be linked to ovarian and breast cancer. Read More

Acute myeloid leukemia may be initiated by single mutation in bone cells

Jan 23, 2014

Acute myeloid leukemia (AML) is a blood cancer, but for many patients the cancer may originate from an unusual source: a mutation in their bone cells.In a study published in the online edition of Nature, researchers at Columbia University Medical Center (CUMC) found that a mutation in the bone cells called osteoblasts, which build new bone, causes AML in mice. Read More

Potential new target in Ewing's Sarcoma

Jan 23, 2014

Ewing's Sarcoma is an aggressive pediatric cancer, most commonly caused by the improper fusion of the gene EWS with the gene FLI1. Though the cause has long been known, therapeutic targeting of this fusion has to date proven very difficult. Read More

Cancer diagnosis doesn't increase a child's risk of post-traumatic stress disorder

Jan 23, 2014

A St. Jude Children's Research Hospital study found that despite being diagnosed with life-threatening illnesses, childhood cancer patients are no more likely than their healthy peers to develop post-traumatic stress disorder (PTSD). The research appears in the current online edition of the Journal of Clinical Oncology. Read More

Longer screening intervals possible with HPV-based tests

Jan 22, 2014

A new study from Karolinska Institutet in Sweden finds that testing for human papilloma virus (HPV) allows for longer time between screening tests when compared to cytology-based testing. The study is published in the scientific journal British Medical Journal (BMJ).Cervical screening programs have until recently relied on cytology to identify women at risk for developing cervical cancer. Read More

International deal to screen potential cancer drugs using DNA 'barcodes'

Jan 22, 2014

An innovative screening technology that tags compounds with unique strands of DNA - like barcodes - will be used to assess up to a billion prototype drug molecules for anti-cancer activity, under a collaboration announced today (22 January 2014) between The Institute of Cancer Research, London, Cancer Research Technology (CRT) and Denmark-based drug discovery company Nuevolution A/S. Read More

Previous Page   Next Page